Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries. Issue 1 (24th January 2022)

• Record Type: Journal Article
• Authors: Hilberg, Ole; Hoffmann-Vold, Anna-Maria; Smith, Vanessa; Bouros, Demosthenes; Kilpeläinen, Maritta; Guiot, Julien; Morais, Antonio; Clemente, Susana; Daniil, Zoe; Papakosta, Despina; Fretheim, Havard; Neves, Sofia; Alfaro, Tiago M.; Antoniou, Katerina M.; Valveny, Neus; Asijee, Guus; Soulard, Stéphane; Wuyts, Wim
• Other Names: Brusselle Guy author non-byline.; Tzilas Vassilios author non-byline.; Tzouvelekis Argyris author non-byline.; Bouros Evangelos author non-byline.; Perkonoja Katariina author non-byline.; Henket Monique author non-byline.; Cunin Marie-Pierre author non-byline.; Rosa Raquel author non-byline.; Martín Teresa author non-byline.; Branco Joana author non-byline.; Alvarenga Maria author non-byline.; Dimeas Ilias author non-byline.; Simopoulou Theodora author non-byline.; Fouka Evangelia author non-byline.; Tsiouprou Ioanna author non-byline.; Zaharias Athanasios author non-byline.; Campainha Sergio author non-byline.; Nogueira Carla author non-byline.; Freitas Sara author non-byline.; Fernandes Vânia author non-byline.; Cabo Carolina author non-byline.; Vasarmidi Irini author non-byline.
• Is Part Of: ERJ open research. Volume 8:Issue 1(2022)
• Publication Date: 2022-01-24
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; Respiration; Respiratory organs -- Diseases; Respiratory organs -- Diseases -- Treatment; Respiratory Tract Diseases; Electronic journals; Fulltext; Internet Resources; Periodicals; Periodical; 616.2005
• DOI: 10.1183/23120541.00597-2021
• Languages: English
• ISSNs: 2312-0541

Abstract

The PERSEIDS study aimed to estimate incidence/prevalence of interstitial lung diseases (ILDs), fibrosing interstitial lung diseases (F-ILDs), idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated ILD (SSc-ILD), other non-IPF F-ILDs and their progressive-fibrosing (PF) forms in six European countries, as current data are scarce. This retrospective, two-phase study used aggregate data (2014–2018). In Phase 1, incident/prevalent cases of ILDs above were identified from clinical databases through an algorithm based on codes/keywords, and incidence/prevalence was estimated. For non-IPF F-ILDs, the relative percentage of subtypes was also determined. In Phase 2, a subset of non-IPF F-ILD cases was manually reviewed to determine the percentage of PF behaviour and usual interstitial pneumonia-like (UIP-like) pattern. A weighted mean percentage of progression was calculated for each country and used to extrapolate incidence/prevalence of progressive-fibrosing ILDs (PF-ILDs). In 2018, incidence/10 5 person-years ranged between 9.4 and 83.6 (ILDs), 7.7 and 76.2 (F-ILDs), 0.4 and 10.3 (IPF), 6.6 and 71.7 (non-IPF F-ILDs), and 0.3 and 1.5 (SSc-ILD); and prevalence/10 5 persons ranged between 33.6 and 247.4 (ILDs), 26.7 and 236.8 (F-ILDs), 2.8 and 31.0 (IPF), 22.3 and 205.8 (non-IPF F-ILDs), and 1.4 and 10.1 (SSc-ILD). Among non-IPF F-ILDs, sarcoidosis was the most frequent subtype. PF behaviour and UIP-like pattern were present in a third of non-IPF F-ILD cases each and hypersensitivity pneumonitis showed the highest percentage of progressive behaviour. Incidence of PF-ILDs ranged between 2.1 and 14.5/10 5 person-years, and prevalence between 6.9 and 78.0/10 5 persons. To our knowledge, PERSEIDS is the first study assessing incidence, prevalence and rate of progression of ILDs across several European countries. Still below the threshold for orphan diseases, the estimates obtained were higher and more variable than reported in previous studies, but differences in study design/population must be considered. The PERSEIDS study provides updated and detailed epidemiological data for ILDs across six European countries. Prevalences ranged between 26.7–236.8 (F-ILDs), 2.8–31.0 (IPF), 22.3–205.8 (non-IPF F-ILDs). A third of non-IPF F-ILD cases showed PF behaviour. https://bit.ly/3wLH7pF